abstract |
FIELD: pharmaceuticals.SUBSTANCE: invention relates to a compound selected from the group described in claim 1 of the invention, or a pharmaceutically acceptable salt thereof. The invention also relates to a pharmaceutical composition, a method for modulating the activity of a follicle-stimulating hormone receptor (FSHR), a method for treatment of a disorder mediated by a follicle stimulating hormone receptor (FSHR), a method for impairment of fertility, an application of the compound, a method for producing the compound.EFFECT: new compounds are produced, potentially applicable as agonists of follicle-stimulating hormone receptors (FSHRs).11 cl, 15 tbl, 26 ex |